Revolutionizing Veterinary Health with Viral Vector-Based Vaccines

Mariner JC, Jones BA, Rich KM, Thevasagayam S, Anderson J, Jeggo M, Cai Y, Peters AR, Roeder PL (2016) The opportunity to eradicate peste des petits ruminants. J Immunol 196:3499–3506. https://doi.org/10.4049/jimmunol.1502625

Article  CAS  PubMed  Google Scholar 

Plotkin S (2014) History of vaccination. Proc Natl Acad Sci 111:12283–12287. https://doi.org/10.1073/pnas.1400472111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schrobback P, Dennis G, Li Y, Mayberry D, Shaw A, Knight-Jones T, Marsh TL, Pendell DL, Torgerson PR, Gilbert W, Huntington B (2023) Approximating the global economic (market) value of farmed animals. Glob Food Sec 39:100722. https://doi.org/10.1016/j.gfs.2023.100722

Article  PubMed  PubMed Central  Google Scholar 

Morens DM, Taubenberger JK, Fauci AS (2023) Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe 31:146–157. https://doi.org/10.1016/j.chom.2022.11.016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Entrican G, Francis MJ (2022) Applications of platform technologies in veterinary vaccinology and the benefits for one health. Vaccine 40:2833–2840. https://doi.org/10.1016/j.vaccine.2022.03.059

Article  CAS  PubMed  Google Scholar 

Van Der Loo JC, Wright JF (2016) Progress and challenges in viral vector manufacturing. Hum Mol Genet 25:R42–R52. https://doi.org/10.1093/hmg/ddv451

Article  CAS  PubMed  Google Scholar 

Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A (2023) The evolution of SARS-CoV-2. Nat Rev Microbiol 21:361–379. https://doi.org/10.1038/s41579-023-00878-2

Article  CAS  PubMed  Google Scholar 

Cui S, Liu Y, Zhao J, Peng X, Lu G, Shi W, Pan Y, Zhang D, Yang P, Wang Q (2022) An updated review on SARS-CoV-2 infection in animals. Viruses 14:1527. https://doi.org/10.3390/v14071527

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sandoval C, Guerrero D, Muñoz J, Godoy K, Souza-Mello V, Farlas J (2023) Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review. Expert Rev Vaccines 22:35–53. https://doi.org/10.1080/14760584.2023.2156861

Article  CAS  PubMed  Google Scholar 

McCann N, O’Connor D, Lambe T, Pollard AJ (2022) Viral vector vaccines. Curr Opin Immunol 77:102210. https://doi.org/10.1016/j.coi.2022.102210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jackson DA, Symons RH, Berg P (1972) Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli. Proc Natl Acad Sci 69:2904–2909. https://doi.org/10.1073/pnas.69.10.2904

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mackett M, Smith GL, Moss B (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci 79:7415–7419. https://doi.org/10.1073/pnas.79.23.7415

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kohn DB, Mitsuya H, Ballow M, Selegue JE, Barankiewicz J, Cohen A, Gelfand E, Anderson WF, Blaese RM (1989) Establishment and characterization of adenosine deaminase-deficient human T cell lines. J Immunol 142:3971–3977. https://doi.org/10.4049/jimmunol.142.11.3971

Article  CAS  PubMed  Google Scholar 

Weyer J, Rupprecht CE, Mans J, Viljoen GJ, Nel LH (2007) Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Vaccine 25:4213–4222. https://doi.org/10.1016/j.vaccine.2007.02.084

Article  CAS  PubMed  Google Scholar 

Barnard AR, Groppe M, MacLaren RE (2015) Gene therapy for choroideremia using an adeno-associated viral (AAV) vector. Cold Spring Harb Perspect Med 5:a017293. https://doi.org/10.1101/cshperspect.a017293

Article  CAS  PubMed Central  Google Scholar 

Tang N, Zhang Y, Pedrera M, Chang P, Baigent S, Moffat K, Shen Z, Nair V, Yao Y (2018) A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR/Cas9 system. Vaccine 36:716–722. https://doi.org/10.1016/j.vaccine.2017.12.025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marzi A, Feldmann F, O’Donnell KL, Hanley PW, Messaoudi I, Feldmann H (2023) Preexisting immunity does not prevent efficacy of VSV-based filovirus vaccines in nonhuman primates. J Infect Dis 6:66. https://doi.org/10.1093/infdis/jiad208

Article  Google Scholar 

Oliveira GP, Rodrigues RAL, Lima MT, Drumond BP, Abrahao JS (2017) Poxvirus host range genes and virus–host spectrum: a critical review. Viruses 9:331. https://doi.org/10.3390/v9110331

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vrba SM, Kirk NM, Brisse ME, Liang Y, Ly H (2020) Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats. Vaccines 8:680. https://doi.org/10.3390/vaccines8040680

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orlova OV, Glazkova DV, Bogoslovskaya EV, Shipulin GA, Yudin SM (2022) Development of modified vaccinia virus Ankara-based vaccines: advantages and applications. Vaccines 10:1516. https://doi.org/10.3390/vaccines10091516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie L, Li Y (2022) Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development. Vaccine. https://doi.org/10.1016/j.vaccine.2022.10.047

Article  PubMed  PubMed Central  Google Scholar 

Satterfield BA, Mire CE, Geisbert TW (2023) Overview of experimental vaccines and antiviral therapeutics for Henipavirus infection. In: Nipah virus: methods and protocols. Springer, New York, pp 1–22. https://doi.org/10.1007/978-1-0716-3283-3_1

Syyam A, Nawaz A, Ijaz A, Sajjad U, Fazil A, Irfan S, Muzaffar A, Shahid M, Idrees M, Malik K, Afzal S (2022) Adenovirus vector system: Construction, history and therapeutic applications. Biotechniques 73:297–305. https://doi.org/10.2144/btn-2022-0051

Article  CAS  PubMed  Google Scholar 

Zhang H, Wang H, An Y, Chen Z (2023) Construction and application of adenoviral vectors. Mol Therapy Nucleic Acids 34:66. https://doi.org/10.1016/j.omtn.2023.09.004

Article  CAS  Google Scholar 

Danthinne X, Imperiale MJ (2000) Production of first generation adenovirus vectors: a review. Gene Ther 7:1707–1714. https://doi.org/10.1038/sj.gt.3301301

Article  CAS  PubMed  Google Scholar 

Sayedahmed EE, Elkashif A, Alhashimi M, Sambhara S, Mittal SK (2020) Adenoviral vector-based vaccine platforms for developing the next generation of influenza vaccines. Vaccines 8:574. https://doi.org/10.3390/vaccines8040574

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez-Aparicio M, Bunuales M, de Landazuri IO, Prieto J, Hernandez-Alcoceba R (2023) Application of a split-Cre system for high-capacity adenoviral vector amplification. Biotechnol J 18:2200227. https://doi.org/10.1002/biot.202200227

Article  CAS  Google Scholar 

Elahi SM, Nazemi-Moghaddam N, Guilbault C, Simoneau M, Gilbert R (2023) Complement

留言 (0)

沒有登入
gif